161 related articles for article (PubMed ID: 17911007)
1. Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas.
Shabani N; Kuhn C; Kunze S; Schulze S; Mayr D; Dian D; Gingelmaier A; Schindlbeck C; Willgeroth F; Sommer H; Jeschke U; Friese K; Mylonas I
Eur J Cancer; 2007 Nov; 43(16):2434-44. PubMed ID: 17911007
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Kunze S; Dian D; Friedl C; Kupka MS; Friese K
Histol Histopathol; 2007 Feb; 22(2):169-76. PubMed ID: 17149689
[TBL] [Abstract][Full Text] [Related]
4. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.
Collins F; MacPherson S; Brown P; Bombail V; Williams AR; Anderson RA; Jabbour HN; Saunders PT
BMC Cancer; 2009 Sep; 9():330. PubMed ID: 19758455
[TBL] [Abstract][Full Text] [Related]
5. Expression of gonadal steroid receptors in the ovaries of post-menopausal women with malignant or benign endometrial pathology: a pilot study.
Panoulis K; Christantoni E; Pliatsika P; Anagnostis P; Goulis DG; Kondi-Pafiti A; Armeni E; Augoulea A; Triantafyllou N; Creatsa M; Lambrinoudaki I
Gynecol Endocrinol; 2015; 31(8):613-7. PubMed ID: 26036714
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression and prognostic significance of oestrogen receptor-alpha, oestrogen receptor-beta, and progesterone receptor in stage 1 adult-type granulosa cell tumour of the ovary.
Hutton SM; Webster LR; Nielsen S; Leung Y; Stewart CJ
Pathology; 2012 Dec; 44(7):611-6. PubMed ID: 23149378
[TBL] [Abstract][Full Text] [Related]
8. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).
Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K
Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082
[TBL] [Abstract][Full Text] [Related]
9. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival.
Kamal AM; Bulmer JN; DeCruze SB; Stringfellow HF; Martin-Hirsch P; Hapangama DK
Br J Cancer; 2016 Mar; 114(6):688-96. PubMed ID: 26930451
[TBL] [Abstract][Full Text] [Related]
11. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
12. Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.
Lenhard M; Tereza L; Heublein S; Ditsch N; Himsl I; Mayr D; Friese K; Jeschke U
BMC Cancer; 2012 Nov; 12():553. PubMed ID: 23176303
[TBL] [Abstract][Full Text] [Related]
13. Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium.
Saegusa M; Okayasu I
Jpn J Cancer Res; 2000 May; 91(5):510-8. PubMed ID: 10835496
[TBL] [Abstract][Full Text] [Related]
14. SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancer.
Penolazzi L; Bonaccorsi G; Gafà R; Ravaioli N; Gabriele D; Bosi C; Lanza G; Greco P; Piva R
Gene; 2019 Aug; 711():143938. PubMed ID: 31220580
[TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.
Chakravarty D; Srinivasan R; Ghosh S; Rajwanshi A; Gopalan S
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):535-42. PubMed ID: 18931615
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
Li M; Zhao L; Shen D; Li X; Wang J; Wei L
Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
[TBL] [Abstract][Full Text] [Related]
20. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.
van der Putten LJM; Visser NCM; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Garcia A; Mancebo G; Alameda F; Trovik J; Kopperud RK; Huvila J; Schrauwen S; Koskas M; Walker F; Weinberger V; Minar L; Jandakova E; Snijders MPLM; van den Berg-van Erp S; Matias-Guiu X; Salvesen HB; Werner HMJ; Amant F; Massuger LFAG; Pijnenborg JMA
Int J Gynecol Cancer; 2018 Mar; 28(3):514-523. PubMed ID: 29324536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
